Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
The announcement came after a quarter where DexCom reported a 7% increase in sales, though net income declined significantly alongside a reduction in earnings per share. During the past quarter ...
9monon MSN
This means that the 1.7 million-plus global Dexcom users won't need to worry about their iPhone being with them and charged ...
Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results